Bone Marrow-derived Mesenchymal Stem Cell Therapy in Retinitis Pigmentosa

CONCLUSION: Retinitis pigmentosa is a progressive, inherited disease that can result in severe vision loss. In retinitis pigmentosa, the application of bone marrow-derived mesenchymal stem cells by deep subtenon injection has positive effects on visual function. No systemic or ophthalmic side effects were detected in the patients during the 6-month follow-up period.PMID:38504575 | DOI:10.2174/011574888X293265240311120103

Source: Current Stem Cell Research and Therapy - March 20, 2024 Category: Stem Cells Authors: Nil Irem Ucgun Cenk Zeki Fikret Mualla Sahin Hamurcu Source Type: research